Trending up over 17 weeks since week of 10/29. last 3 weeks have been down. attempt was there for continuation but just couldn't make it with all the FDA attention (or lack thereof) on CBD and Elixinol is dependant on the US for most of their market. Not a whole lot of downside here but is a good one, and one of the few profitable pure CBD plays out there. all in my opinion, in case that wasn't obvious. : )
News 
Market Data 
Discover 
AI
